Clinical Trials for Douglas Johnson

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
OtherVICCMEL12117
02/18/2013
A Multi-Site Retrospective Observational Study of US Patients with Unresectable or Metastatic Melanoma Receiving Ipilimumab (YERVOY?) as First-Line Therapy

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.